Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy-Reference-Cited by-同舟云学术

Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy

Published:2014-11-19 Issue:48 Volume:111 Page:17266-17271
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proc Natl Acad Sci USA

Author:

Zhang Suping,Cui Bing,Lai Hsien,Liu Grace,Ghia Emanuela M.,Widhopf George F.,Zhang Zhuhong,Wu Christina C. N.,Chen Liguang,Wu Rongrong,Schwab Richard,Carson Dennis A.,Kipps Thomas J.

Funder

HHS | NIH | National Cancer Institute (NCI)

California Institute for Regenerative Medicine (CIRM)

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference50 articles.

1. Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

2. Carboplatin and paclitaxel in ovarian carcinoma: A phase I study of the Gynecologic Oncology Group;Bookman;J Clin Oncol,1996

3. Epithelial ovarian cancer: Focus on targeted therapy

4. Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells

5. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel humanized monoclonal antibodies against ROR1 for cancer therapy;Molecular Cancer;2024-08-13

2. Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies;Science China Life Sciences;2024-08-12

3. Extracellular vesicles and cancer stem cells: a deadly duo in tumor progression;Oncology Reviews;2024-07-18

4. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis;Clinical and Translational Medicine;2024-04-30

5. Targeting Other Promising Cell Surface Receptors;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21